Skip to main content
. 2019 Dec 6;2019(1):187–193. doi: 10.1182/hematology.2019000026

Figure 1.

Figure 1.

Clinical events in extended thromboprophylaxis trials investigating both symptomatic and asymptomatic VTE. ADOPT, Apixaban Dosing to Optimize Protection from Thrombosis; APEX, The Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban; EXCLAIM, Extended Prophylaxis for Venous Thromboembolism in Acutely Ill Medical Patients with Prolonged Immobilization trial; MAGELLAN, Venous Thromboembolic Event [VTE] Prophylaxis in Medically Ill Patients.